Aptitude Awarded Up to $54M BARDA Funding for At-Home Diagnostics
BARDA is partnering with Aptitude Medical Systems to accelerate development of two at-home molecular diagnostic tests for COVID-19 and influenza. ...
BARDA is partnering with Aptitude Medical Systems to accelerate development of two at-home molecular diagnostic tests for COVID-19 and influenza. ...
Northwestern University faculty and spinoff company developed the new technology A new highly sensitive, easy-to-use test for COVID-19 that requires ...
The U.S. Department of Health and Human Services (HHS) announced on Feb 10. it will acquire 600,000 treatment courses of ...
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the ACON Laboratories Flowflex COVID-19 Home Test, ...
On Oct. 14 and 15, the FDA Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet to discuss the ...
BARDA renews collaboration with OraSure Technologies to support InteliSwab™ COVID-19 Rapid Test 510(k) Clearance and CLIA Waiver BARDA and OraSure ...
The U.S. Food and Drug Administration approved the Pfizer-BioNTech coronavirus vaccine for use in people 16 and older on Aug. ...
Thirty percent of unvaccinated American adults say they’re waiting for the COVID-19 vaccines currently authorized for emergency use to be ...
Around 85% of adults (44.8 million people) in the UK have received one vaccine dose and 63% (33 million people) ...
The U.S. Food and Drug Administration has authorized the use of the Johnson & Johnson coronavirus vaccine in adults. Maureen ...
South Africa has recently started its COVID-19 vaccine roll-out. Around the country, frontline healthcare workers are getting a jab of ...
Gary Disbrow, Ph.D., BARDA Director at HHS/ASPR, explains the public-private collaboration and platform technologies brought to bear for COVID-19 vaccines. ...
There are now two COVID-19 vaccines that, at least according to preliminary reports, appear to be 94.5% and 95% effective. ...
Pfizer Inc. and BioNTech SE announced they will submit a request today to the U.S. Food and Drug Administration (FDA) for Emergency Use ...
The U.S. Food and Drug Administration has granted emergency use authorization for scientists at UCLA Health to begin using a ...
Eli Lilly and Company today announced additional details on its SARS-CoV-2 neutralizing antibody programs – including interim data on combination therapy ...
The U.S. Food and Drug Administration granted an Emergency Use Authorization (EUA) on Sep. 1 to DetectaChem for the MobileDetect ...
On March 28, the Food and Drug Administration (FDA) exercised its Emergency Use Authorization (EUA) authority to allow the use ...
Kantaro Biosciences, the new joint venture of Mount Sinai Health System and Renalytix AI, will develop and scale production of ...
The U.S. Food and Drug Administration issued an alert today about early data that suggests potential inaccurate results from using ...